ALNY vs KFS · P/E 76, rev $1.29B vs rev $109.4M
Alnylam Pharmaceuticals Inc (ALNY) versus Kingsway Financial Services Inc (KFS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Kingsway Financial Services Inc (KFS) is a asset management company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported KFS revenue for 2024-12-31 was $109.4M. Net income was -$8.3M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. KFS currently screens at market cap $307.2M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. KFS currently screens at market cap $307.2M.
Not investment advice. Open the ALNY and KFS stock pages for the full models.
Not investment advice.